drugset / Trial / NCT00051948
TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a dose-ranging, open label, Phase 1-2a study of TLK286 in combination with Paraplatin (carboplatin) in patients with recurrent ovarian cancer.
Timeline
- Start
- 2003-01
- Primary completion
- 2005-01
- Completion
- 2005-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | canfosfamide | Small molecule | — | — |